Analysis of COVID-19 Name Varieties in Chinese Mass and Social Media.

The sudden appearance of a new epidemic disease in China created the need for names identifying that disease. Between December 2019 and January 2020, a variety of severe pneumonia-related disease names suddenly appeared, and more name varieties kept coming up afterwards. To better understand the introduction and spread of these names, 16 different COVID-19-related name varieties were selected covering the period from the end of December 2019, when the epidemic started, to mid-March 2020, a moment at which the term competition had stabilized. By way of big data analysis, the initiation and distribution of the 16 names across the media landscape was traced with regard to the impact of different media platforms, while the distribution frequency of each of the selected terms was mapped, resulting in a distinction of three groups of disease names, each with a different media and time profile. The results were discussed based on the hypotheses of disease confusion by name variety and management failures in absence of clear language governance at the national and global levels. The analysis of the data led to a refutation of both hypotheses. Based on this discussion, the study offers empirically based suggestions for the WHO in their naming practices and further research.

Aspergillosis Complicating Severe Coronavirus Disease.

Aspergillosis complicating severe influenza infection has been increasingly detected worldwide. Recently, coronavirus disease-associated pulmonary aspergillosis (CAPA) has been detected through rapid reports, primarily from centers in Europe. We provide a case series of CAPA, adding 20 cases to the literature, with review of pathophysiology, diagnosis, and outcomes. The syndromes of pulmonary aspergillosis complicating severe viral infections are distinct from classic invasive aspergillosis, which is recognized most frequently in persons with neutropenia and in other immunocompromised persons. Combined with severe viral infection, aspergillosis comprises a constellation of airway-invasive and angio-invasive disease and results in risks associated with poor airway fungus clearance and killing, including virus- or inflammation-associated epithelial damage, systemic immunosuppression, and underlying lung disease. Radiologic abnormalities can vary, reflecting different pathologies. Prospective studies reporting poor outcomes in CAPA patients underscore the urgent need for strategies to improve diagnosis, prevention, and therapy.